February 7, 2017 — In December, IntellaPACS LLC announced its corporate name change to Emergent Connect LLC. As of Jan ...
Healthcare analytics company Innovaccer Inc. announced the launch of its holistic MIPS Platform designed to enable providers to deliver better clinical outcomes. The platform does this by helping providers monitor performances, understand population, efficiently manage data and easily submit it to the Centers for Medicare and Medicaid Services (CMS).
IBA (Ion Beam Applications S.A.) recently announced the first clinical implementation of its Dolphin Online Ready Patient QA (quality assurance) and Monitoring solution in the United Kingdom.
eHealth Saskatchewan plays a vital role in providing IT services to patients, health care providers, and partners such ...
A newly developed breast magnetic resonance imaging (MRI) exam protocol, the first of its kind being offered in the Pacific Northwest, is now being performed at Via Radiology in north Seattle.
Blue Earth Diagnostics and Siemens’ PETNET Solutions announced that an increasing number of radiopharmacies will offer Blue Earth Diagnostics’ Axumin (fluciclovine F-18) positron emission tomography (PET) imaging agent through PETNET’s national network.
Magnetic resonance imaging (MRI) exams before and after space missions reveal that astronauts' brains compress and expand during spaceflight, according to a University of Michigan study.
While most women understand the importance of health screenings, an estimated 72 million have missed or postponed a ...
Onxeo S.A. and the Institut Curie launched a series of studies on World Cancer Day (Feb. 4) aimed at investigating the benefits of combining radiotherapy, DNA repair inhibitors and immunotherapy. This highly innovative combination would make it possible to reverse the disease in patients suffering from drug-resistant cancers.
In humans, the part of the brain that's responsible for face recognition continues to grow into adulthood, according to a new study published in Science. The results are surprising, since brain development is largely thought to involve synaptic pruning, rather than growth. The ability to recognize faces, which is critical for everyday social interactions, improves from childhood to adulthood.
At the 2016 Radiological Society of North America (RSNA) annual meeting, GE Healthcare unveiled Freelium, a magnet technology designed to use 1 percent of liquid helium compared to conventional magnetic resonance imaging (MRI) magnets. Instead of the average 2,000 liters of precious liquid helium, Freelium is designed to use only about 20 liters.
Fujifilm’s APERTO Lucent is a 0.4T mid-field, open MRI system addressing today’s capability and image quality needs ...
A study published in the February issue of The Journal of Nuclear Medicine demonstrates the potential of extending peptide receptor radionuclide therapy targeting the somatostatin receptor to other types of malignancies beyond neuroendocrine tumors (NETs). The theranostic pairing of Netspot (Ga-68 DOTATATE, which is U.S. Food and Drug Administration [FDA]-approved) and Lutathera (Lu-177-DOTATATE, currently under FDA review) has already shown that it can significantly improve progression-free survival in patients with somatostatin receptor-positive NETs.
At the Society of Cardiac Magnetic Resonance (SCMR) 20th Annual Scientific Sessions, GE Healthcare showcased cmr42 cardiac magnetic resonance imaging (MRI) post-processing software integrated onto its GE Advantage Workstation (AW) and AW Server platforms.
Get the New Executive Brief, Making the Shift to Patient-Centered Radiology: Strategies for Success, featuring research from the Ambra advisory board
SPONSORED CONTENT — Fujifilm’s latest CT technology brings exceptional image quality to a compact and user- and patient ...
Aspyra LLC announced that they have received the CE Mark on their picture archiving and communication system (PACS) products, including MedVIEW with AccessNET. The company’s PACS products were evaluated by BSI Group (notified body number 0086) to validate that the products and processes used meet the requirements for CE mark.
Adding hormonal therapy to radiation treatment can significantly improve the average long-term survival of men with prostate cancer who have had their prostate gland removed, according to a new Cedars-Sinai study published in the Feb. 2 issue of the New England Journal of Medicine. The regimen also can reduce the frequency of spread of the cancer, the study found.
Tom Kloetzly, sales and marketing VP for Shimadzu Medical Systems USA, explains the evolution of Shimadzu Corporation since its founding 142 years ago. Kloetzly focuses on the Trinias Interventional X-ray lineshown at RSNA.
Focused ultrasound (FUS), also called high-intensity focused ultrasound (HIFU), has gained a lot of interest in recent years as noninvasive cancer therapy that does not require radiation, chemotherapy, or surgery, resulting is less collateral damage to the patient. FUS is performed as an out-patient procedure, so it can eliminate the usual two weeks of recovery needed from most types of surgery.
As the new Congress and administration wrestle with policy decisions on the provision of high-quality, affordable health coverage, the American Society for Radiation Oncology (ASTRO) urges policymakers to prioritize reforms that avoid disruption in coverage and care. Patients fighting cancer should not have to battle for insurance while they battle for their lives, the association said.
According to a new report by the Harvey L. Neiman Health Policy Institute, physician-focused payment models (PFPMs) provide a compelling opportunity for radiologists to demonstrate and be rewarded for their unique contributions toward patient care. The report also said PFPMs may foster greater radiologist participation in advanced alternative payment models (APMs) under the Medicare Access and CHIP Reauthorization Act (MACRA) of 2015. The study is published online in the Journal of the American College of Radiology (JACR).
Fujifilm Medical Systems U.S.A. Inc. and Fujifilm SonoSite Inc. will present its comprehensive Synapse Enterprise Imaging product portfolio and its SonoSite iViz solution at the Healthcare Information and Management Systems Society (HIMSS) conference and exhibition Feb. 19-23, 2017 in Orlando, Fla. The company announced it will also sponsor an educational session titled “Value-based Care, Enterprise Imaging and the Future of Artificial Intelligence and Deep Learning.”
Discover GE Healthcare’s Interventional Image Guided Systems and find out how our latest technologies including the Discovery IGS 730 and Discovery IGS 740 products and our ASSIST solutions can help you provide better outcomes for your patients. These solutions were included in the VIDEO "Editor's Choice of Most Innovative New Technology at RSNA 2015."